Eyebright Medical Technology (Beijing) Co., Ltd. (SHA:688050)

SHA:688050 Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue Revenue Growth	1,524	1,483	1,410	951.18	579.5	433.07
Revenue Growth	4.60%	5.16%	48.24%	64.14%	33.81%	58.61%
Gross Profit Gross Profit Growth	940.25	926.15	930.19	721.14	491.15	364.99
Operating Income Operating Income Growth	362.43	364.93	437.5	308.16	231.62	157.89
Net Income Net Income Growth	264.89	268.17	388.4	303.98	232.69	171.34
Earnings Per Share EPS Growth	1.37	1.40	2.05	1.60	1.23	0.91
EPS Growth	-31.31%	-31.71%	28.13%	30.31%	35.58%	50.93%

Revenue by Geography

Chart

Fiscal Year	FY 2025
Period Ending	Dec 31, 2025
China China Growth	1,377
Overseas Overseas Growth	105.48
Total Total Growth	1,483

Cash & Debt

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Investments Cash & Investments Growth	728.83	796.14	496.17	556.78	836.86	953.35
Total Debt Total Debt Growth	1,299	601.5	608.9	419.23	162.79	154.85
Net Cash (Debt) Net Cash Growth	-570.1	194.64	-112.73	137.55	674.07	798.5
Net Cash Growth	-	-	-	-79.59%	-15.58%	-19.11%
Net Cash Per Share Net Cash Per Share Growth	-2.96	1.02	-0.60	0.72	3.56	4.22

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Operating Cash Flow Operating Cash Flow Growth	312.35	369.15	347.75	212.62	250.13	219.3
Capital Expenditures CapEx Growth	-97.96	-123.14	-329.48	-370.34	-271.03	-311.22
Free Cash Flow Free Cash Flow Growth	214.39	246.01	18.27	-157.72	-20.9	-91.92
Free Cash Flow Growth	95.86%	1246.45%	-	-	-	-

Margins

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Gross Margin	61.71%	62.46%	65.97%	75.82%	84.75%	84.28%
Operating Margin	23.79%	24.61%	31.03%	32.40%	39.97%	36.46%
Pretax Margin	18.82%	19.51%	30.57%	34.45%	45.57%	43.36%
Profit Margin	17.38%	18.09%	27.55%	31.96%	40.15%	39.56%
FCF Margin	14.07%	16.59%	1.30%	-16.58%	-3.61%	-21.22%

Dividends

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 2, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Dividend Per Share Dividend Per Share Growth	0.320	0.320	0.350	0.272	0.283	0.206
Dividend Per Share Growth	-8.57%	-8.57%	28.58%	-3.92%	37.79%	32.13%
Dividend Yield	0.77%	0.53%	0.39%	0.29%	0.22%	0.18%

Valuation

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 2, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
PE Ratio	30.45	43.75	44.42	59.57	104.27	129.00
Forward PE	21.67	26.56	29.85	46.16	81.03	105.28
P/FCF Ratio	37.73	47.69	944.35	-	-	-
PS Ratio	5.31	7.91	12.24	19.04	41.87	51.04

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 31, 2026

Data Sources Report a data error